{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:58:23Z","timestamp":1777111103661,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1136\/ard.2007.076406","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T00:50:48Z","timestamp":1187657448000},"page":"462-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic"],"prefix":"10.1016","volume":"67","author":[{"given":"A","family":"Mor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"C O","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P B","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.076406_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(04)01004-7","article-title":"Tuberculosis in New York City: recent lessons and a look ahead","volume":"4","author":"Paolo","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/ard.2007.076406_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2002.004598","article-title":"High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumor necrosis factor inhibitors","volume":"62","author":"Vanhoof","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076406_bib3","first-page":"517","article-title":"Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities","volume":"23","author":"Yazici","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2007.076406_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.semarthrit.2003.12.003","article-title":"The use of methotrexate in rheumatoid arthritis","volume":"34","author":"Borchers","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2007.076406_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009748709102922","article-title":"Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis","volume":"16","author":"Szanto","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2007.076406_bib6","first-page":"2374","article-title":"Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement","volume":"31","author":"Hornung","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.076406_bib7","first-page":"735","article-title":"Update: Adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2014United States","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1136\/ard.2007.076406_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-3062.2005.00103.x","article-title":"Prospective randomized control trial of Isoniazid chemoprophylaxis during renal replacement therapy","volume":"7","author":"Vikrant","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1136\/ard.2007.076406_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000171611","article-title":"Isoniazid-related hepatitis","volume":"15","author":"Vasudeva","year":"1997","journal-title":"Dig Dis"},{"key":"10.1136\/ard.2007.076406_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"Foutain","year":"2005","journal-title":"Chest"},{"key":"10.1136\/ard.2007.076406_bib11","unstructured":"http:\/\/www.medicinenet.com\/isoniazid_inh\/article.htm (accessed 28 January 2008)."},{"key":"10.1136\/ard.2007.076406_bib12","first-page":"699","article-title":"CYP2E1 mediated isoniazid-induced hepatotoxicity in rats","volume":"25","author":"Yue","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1136\/ard.2007.076406_bib13","first-page":"683","article-title":"Tuberculosis associated with blocking agents against tumor necrosis factor-alpha\u2014California 2002\u20132003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.076406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:47:00Z","timestamp":1737352020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724218380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0003496724218380"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.076406","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.076406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}